Principles of Cancer Biotherapy -

Principles of Cancer Biotherapy

Buch | Hardcover
688 Seiten
2003 | 4th Revised edition
Kluwer Academic Publishers (Verlag)
978-1-4020-0706-4 (ISBN)
197,90 inkl. MwSt
  • Titel erscheint in neuer Auflage
  • Artikel merken
Summarizes an evolving science and a rapidly changing medical practice. This textbook illustrates methods of thinking and strategies for control of cancer. It illustrates why it is so important to the patients, for researchers and clinicians to explore and apply these opportunities in cancer biotherapy.
At the time of the first edition of Principles of Cancer Biotherapy in 1987, this book represented the first comprehensive textbook on biological therapy. In 1991, when the second edition was published, there was still some doubt on the part of many oncologists and cancer researchers as to the therapeutic value of these new approaches. By 2003 and the fourth edition, it was generally agreed that biopharmaceuticals were producing major opportunities for new cancer therapies. Cancer biotherapy has now truly matured into the fourth modality of cancer treatment. This fifth revised edition describes the tremendous progress that has been made in recent years using biologicals in cancer treatment. This book summarizes an evolving science and a rapidly changing medical practice in biotherapy. In this new millennium, it is now possible to envision a much more diversified system of cancer research and treatment that will afford greater opportunities for a patient's personalized cancer treatment. This was first envisioned in the 1987 initial edition of this textbook and is now a "new" and popular approach to cancer treatment.
Some forms of cancer biotherapy use the strategy of tumor stabilization and control though continued biological therapy, akin to the use of insulin in the treatment of diabetes. This textbook illustrates new methods of thinking and new strategies for control of cancer. It is always difficult to move from past dogma to future opportunity, but this fifth edition of Principles of Cancer Biotherapy illustrates why it is so important to the patients for researchers and clinicians to explore and quickly apply these new opportunities in cancer biotherapy.

1. Cancer Biotherapy: General Principles; Oldham 2. The Pathogenesis of Cancer Metastasis: Relevance to Biotherapy; Fidler 3. Developmental Therapeutics and the Design of Clinical Trials; Oldham 4. Recombinant Proteins and Genomics in Cancer Therapy; Mehta, Ozpolat 5. Current Concepts in Immunology; Oldham 6. Therapeutic Approaches to Cancer-Associated Immune Suppression; Oldham 7. Cancer Vaccines; Foon 8. Lymphokines and Cytokines Lewko; Oldham 9. Interferons: Therapy in Cancer; Goldstein 10. Antibody Therapy; Dillman 11. Immunotoxins; Frankel 12. Drug Immunoconjugates; Oldham, Foon, Safa 13. Radiolabeled Monoclonal Antibodies for Localization and Treatment of Metastatic Cancer; Meredith 14. Stem Cell/Bone Marrow Transplantation as Biotherapy; Oldham 15. Update on the Laboratory Aspects of the Cellular Immunotherapy of Human Cancer; Yannelli 16. Growth and Maturation Factors in Cancer; Oldham, Mehta, Ozpalat 17. Granulocyte Colony-Stimulating Factor: Biology and Clinical Potential; Foote 18. Granulocyte-Macrophage Colony-Stimulating factor (GM-CSF): Biology and Clinical Status; Morstyn, Foote 19. Clinical Approaches to Cancer Gene Therapy; Buchsbaum 20. Regulatory Process for Approval of Biologicals for Cancer Therapy; Grillo-Lopez 21. Cancer Biotherapy: 1998 Disease-Related Activity; Oldham, Dillman 22. Speculation for 2008 and Beyond; Oldham

Erscheint lt. Verlag 31.8.2003
Sprache englisch
Maße 195 x 260 mm
Gewicht 1645 g
Einbandart gebunden
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 1-4020-0706-X / 140200706X
ISBN-13 978-1-4020-0706-4 / 9781402007064
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00

von Stein Husebø; Gebhard Mathis; Eva Katharina Masel

Buch | Softcover (2023)
Springer (Verlag)
49,99